Hunter Gillies
Chief Tech/Sci/R&D Officer presso AEROVATE THERAPEUTICS, INC.
Patrimonio netto: 96 132 $ in data 31/03/2024
Profilo
Hunter Gillies is currently the Chief Medical Officer at Aerovate Therapeutics, Inc. He previously worked as the Senior Director-Clinical Research at Gilead Sciences, Inc. from 2010 to 2015.
He also worked as the Chief Medical Officer at Bellerophon Therapeutics, Inc. Dr. Gillies received his undergraduate and graduate degrees from the University of Cape Town.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2024 | 3 251 ( 0.01% ) | 96 132 $ | 31/03/2024 |
Posizioni attive di Hunter Gillies
| Società | Posizione | Inizio |
|---|---|---|
| AEROVATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2020 |
Precedenti posizioni note di Hunter Gillies
| Società | Posizione | Fine |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/12/2015 |
| BELLEROPHON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Hunter Gillies
| University of Cape Town | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| AEROVATE THERAPEUTICS, INC. | Health Technology |
- Borsa valori
- Insiders
- Hunter Gillies
